カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の人間用狂犬病予防接種市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Human Rabies Vaccination Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19398）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19398
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の人間用狂犬病予防接種市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

人間用狂犬病予防接種市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の人間用狂犬病予防接種の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

人間用狂犬病予防接種市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・Vero細胞、BHK、ニワトリ胚細胞、ヒト二倍体細胞、その他

用途別セグメントは次のように区分されます。
・前露光、後露光

世界の人間用狂犬病予防接種市場の主要な市場プレーヤーは以下のとおりです。
・Bharat Biotech、Bavarian Nordic、Sanofi-Pasteur、Chengda Bio、KANGH、Prcmise、Henan Grand Biopharma、Zhuoyi Biological、ZhongKe Biopharm、Ningbo Rongan Biological、Indian Immunologicals

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、人間用狂犬病予防接種製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な人間用狂犬病予防接種メーカーの企業概要、2019年～2022年までの人間用狂犬病予防接種の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な人間用狂犬病予防接種メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別人間用狂犬病予防接種の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの人間用狂犬病予防接種の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での人間用狂犬病予防接種市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および人間用狂犬病予防接種の産業チェーンを掲載しています。
・第13、14、15章では、人間用狂犬病予防接種の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 人間用狂犬病予防接種の概要
- 種類別分析（2017年vs2021年vs2028年）：Vero細胞、BHK、ニワトリ胚細胞、ヒト二倍体細胞、その他
- 用途別分析（2017年vs2021年vs2028年）：前露光、後露光
- 世界の人間用狂犬病予防接種市場規模・予測
- 世界の人間用狂犬病予防接種生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Bharat Biotech、Bavarian Nordic、Sanofi-Pasteur、Chengda Bio、KANGH、Prcmise、Henan Grand Biopharma、Zhuoyi Biological、ZhongKe Biopharm、Ningbo Rongan Biological、Indian Immunologicals
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：Vero細胞、BHK、ニワトリ胚細胞、ヒト二倍体細胞、その他
・用途別分析2017年-2028年：前露光、後露光
・人間用狂犬病予防接種の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・人間用狂犬病予防接種のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・人間用狂犬病予防接種のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・人間用狂犬病予防接種の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・人間用狂犬病予防接種の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Human Rabies Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Rabies Vaccination market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Pre-exposure accounting for % of the Human Rabies Vaccination global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Vero Cell segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Rabies Vaccination include Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, and KANGH, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Rabies Vaccination market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others
Market segment by Application can be divided into
Pre-exposure
Post-exposure
The key market players for global Human Rabies Vaccination market are listed below:
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Rabies Vaccination product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Rabies Vaccination, with price, sales, revenue and global market share of Human Rabies Vaccination from 2019 to 2022.
Chapter 3, the Human Rabies Vaccination competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rabies Vaccination breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Rabies Vaccination market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Rabies Vaccination.
Chapter 13, 14, and 15, to describe Human Rabies Vaccination sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Human Rabies Vaccination Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Rabies Vaccination Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Vero Cell
1.2.3 BHK
1.2.4 Chick Embryo Cell
1.2.5 Human Diploid Cells
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Rabies Vaccination Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pre-exposure
1.3.3 Post-exposure
1.4 Global Human Rabies Vaccination Market Size & Forecast
1.4.1 Global Human Rabies Vaccination Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Rabies Vaccination Sales in Volume (2017-2028)
1.4.3 Global Human Rabies Vaccination Price (2017-2028)
1.5 Global Human Rabies Vaccination Production Capacity Analysis
1.5.1 Global Human Rabies Vaccination Total Production Capacity (2017-2028)
1.5.2 Global Human Rabies Vaccination Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Rabies Vaccination Market Drivers
1.6.2 Human Rabies Vaccination Market Restraints
1.6.3 Human Rabies Vaccination Trends Analysis
2 Manufacturers Profiles
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech Human Rabies Vaccination Product and Services
2.1.4 Bharat Biotech Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bavarian Nordic
2.2.1 Bavarian Nordic Details
2.2.2 Bavarian Nordic Major Business
2.2.3 Bavarian Nordic Human Rabies Vaccination Product and Services
2.2.4 Bavarian Nordic Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi-Pasteur
2.3.1 Sanofi-Pasteur Details
2.3.2 Sanofi-Pasteur Major Business
2.3.3 Sanofi-Pasteur Human Rabies Vaccination Product and Services
2.3.4 Sanofi-Pasteur Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Chengda Bio
2.4.1 Chengda Bio Details
2.4.2 Chengda Bio Major Business
2.4.3 Chengda Bio Human Rabies Vaccination Product and Services
2.4.4 Chengda Bio Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 KANGH
2.5.1 KANGH Details
2.5.2 KANGH Major Business
2.5.3 KANGH Human Rabies Vaccination Product and Services
2.5.4 KANGH Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Prcmise
2.6.1 Prcmise Details
2.6.2 Prcmise Major Business
2.6.3 Prcmise Human Rabies Vaccination Product and Services
2.6.4 Prcmise Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Henan Grand Biopharma
2.7.1 Henan Grand Biopharma Details
2.7.2 Henan Grand Biopharma Major Business
2.7.3 Henan Grand Biopharma Human Rabies Vaccination Product and Services
2.7.4 Henan Grand Biopharma Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Zhuoyi Biological
2.8.1 Zhuoyi Biological Details
2.8.2 Zhuoyi Biological Major Business
2.8.3 Zhuoyi Biological Human Rabies Vaccination Product and Services
2.8.4 Zhuoyi Biological Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 ZhongKe Biopharm
2.9.1 ZhongKe Biopharm Details
2.9.2 ZhongKe Biopharm Major Business
2.9.3 ZhongKe Biopharm Human Rabies Vaccination Product and Services
2.9.4 ZhongKe Biopharm Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Ningbo Rongan Biological
2.10.1 Ningbo Rongan Biological Details
2.10.2 Ningbo Rongan Biological Major Business
2.10.3 Ningbo Rongan Biological Human Rabies Vaccination Product and Services
2.10.4 Ningbo Rongan Biological Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Indian Immunologicals
2.11.1 Indian Immunologicals Details
2.11.2 Indian Immunologicals Major Business
2.11.3 Indian Immunologicals Human Rabies Vaccination Product and Services
2.11.4 Indian Immunologicals Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Rabies Vaccination Breakdown Data by Manufacturer
3.1 Global Human Rabies Vaccination Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Rabies Vaccination Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Rabies Vaccination
3.4 Market Concentration Rate
3.4.1 Top 3 Human Rabies Vaccination Manufacturer Market Share in 2021
3.4.2 Top 6 Human Rabies Vaccination Manufacturer Market Share in 2021
3.5 Global Human Rabies Vaccination Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Rabies Vaccination Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Rabies Vaccination Market Size by Region
4.1.1 Global Human Rabies Vaccination Sales in Volume by Region (2017-2028)
4.1.2 Global Human Rabies Vaccination Revenue by Region (2017-2028)
4.2 North America Human Rabies Vaccination Revenue (2017-2028)
4.3 Europe Human Rabies Vaccination Revenue (2017-2028)
4.4 Asia-Pacific Human Rabies Vaccination Revenue (2017-2028)
4.5 South America Human Rabies Vaccination Revenue (2017-2028)
4.6 Middle East and Africa Human Rabies Vaccination Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Rabies Vaccination Sales in Volume by Type (2017-2028)
5.2 Global Human Rabies Vaccination Revenue by Type (2017-2028)
5.3 Global Human Rabies Vaccination Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Rabies Vaccination Sales in Volume by Application (2017-2028)
6.2 Global Human Rabies Vaccination Revenue by Application (2017-2028)
6.3 Global Human Rabies Vaccination Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Rabies Vaccination Sales by Type (2017-2028)
7.2 North America Human Rabies Vaccination Sales by Application (2017-2028)
7.3 North America Human Rabies Vaccination Market Size by Country
7.3.1 North America Human Rabies Vaccination Sales in Volume by Country (2017-2028)
7.3.2 North America Human Rabies Vaccination Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Rabies Vaccination Sales by Type (2017-2028)
8.2 Europe Human Rabies Vaccination Sales by Application (2017-2028)
8.3 Europe Human Rabies Vaccination Market Size by Country
8.3.1 Europe Human Rabies Vaccination Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Rabies Vaccination Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Rabies Vaccination Sales by Type (2017-2028)
9.2 Asia-Pacific Human Rabies Vaccination Sales by Application (2017-2028)
9.3 Asia-Pacific Human Rabies Vaccination Market Size by Region
9.3.1 Asia-Pacific Human Rabies Vaccination Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Rabies Vaccination Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Rabies Vaccination Sales by Type (2017-2028)
10.2 South America Human Rabies Vaccination Sales by Application (2017-2028)
10.3 South America Human Rabies Vaccination Market Size by Country
10.3.1 South America Human Rabies Vaccination Sales in Volume by Country (2017-2028)
10.3.2 South America Human Rabies Vaccination Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Rabies Vaccination Sales by Type (2017-2028)
11.2 Middle East & Africa Human Rabies Vaccination Sales by Application (2017-2028)
11.3 Middle East & Africa Human Rabies Vaccination Market Size by Country
11.3.1 Middle East & Africa Human Rabies Vaccination Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Rabies Vaccination Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Rabies Vaccination and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Rabies Vaccination
12.3 Human Rabies Vaccination Production Process
12.4 Human Rabies Vaccination Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Rabies Vaccination Typical Distributors
13.3 Human Rabies Vaccination Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Human Rabies Vaccination Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Rabies Vaccination Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Bharat Biotech Major Business
Table 5. Bharat Biotech Human Rabies Vaccination Product and Services
Table 6. Bharat Biotech Human Rabies Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 8. Bavarian Nordic Major Business
Table 9. Bavarian Nordic Human Rabies Vaccination Product and Services
Table 10. Bavarian Nordic Human Rabies Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi-Pasteur Major Business
Table 13. Sanofi-Pasteur Human Rabies Vaccination Product and Services
Table 14. Sanofi-Pasteur Human Rabies Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Chengda Bio Basic Information, Manufacturing Base and Competitors
Table 16. Chengda Bio Major Business
Table 17. Chengda Bio Human Rabies Vaccination Product and Services
Table 18. Chengda Bio Human Rabies Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. KANGH Basic Information, Manufacturing Base and Competitors
Table 20. KANGH Major Business
Table 21. KANGH Human Rabies Vaccination Product and Services
Table 22. KANGH Human Rabies Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Prcmise Basic Information, Manufacturing Base and Competitors
Table 24. Prcmise Major Business
Table 25. Prcmise Human Rabies Vaccination Product and Services
Table 26. Prcmise Human Rabies Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Henan Grand Biopharma Basic Information, Manufacturing Base and Competitors
Table 28. Henan Grand Biopharma Major Business
Table 29. Henan Grand Biopharma Human Rabies Vaccination Product and Services
Table 30. Henan Grand Biopharma Human Rabies Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Zhuoyi Biological Basic Information, Manufacturing Base and Competitors
Table 32. Zhuoyi Biological Major Business
Table 33. Zhuoyi Biological Human Rabies Vaccination Product and Services
Table 34. Zhuoyi Biological Human Rabies Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. ZhongKe Biopharm Basic Information, Manufacturing Base and Competitors
Table 36. ZhongKe Biopharm Major Business
Table 37. ZhongKe Biopharm Human Rabies Vaccination Product and Services
Table 38. ZhongKe Biopharm Human Rabies Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Ningbo Rongan Biological Basic Information, Manufacturing Base and Competitors
Table 40. Ningbo Rongan Biological Major Business
Table 41. Ningbo Rongan Biological Human Rabies Vaccination Product and Services
Table 42. Ningbo Rongan Biological Human Rabies Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 44. Indian Immunologicals Major Business
Table 45. Indian Immunologicals Human Rabies Vaccination Product and Services
Table 46. Indian Immunologicals Human Rabies Vaccination Sales (Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Human Rabies Vaccination Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Units)
Table 48. Global Human Rabies Vaccination Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Human Rabies Vaccination, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Human Rabies Vaccination Production Capacity by Company, (Units): 2020 VS 2021
Table 51. Head Office and Human Rabies Vaccination Production Site of Key Manufacturer
Table 52. Human Rabies Vaccination New Entrant and Capacity Expansion Plans
Table 53. Human Rabies Vaccination Mergers & Acquisitions in the Past Five Years
Table 54. Global Human Rabies Vaccination Sales by Region (2017-2022) & (Units)
Table 55. Global Human Rabies Vaccination Sales by Region (2023-2028) & (Units)
Table 56. Global Human Rabies Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Human Rabies Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Human Rabies Vaccination Sales by Type (2017-2022) & (Units)
Table 59. Global Human Rabies Vaccination Sales by Type (2023-2028) & (Units)
Table 60. Global Human Rabies Vaccination Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Human Rabies Vaccination Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Human Rabies Vaccination Price by Type (2017-2022) & (US$/Unit)
Table 63. Global Human Rabies Vaccination Price by Type (2023-2028) & (US$/Unit)
Table 64. Global Human Rabies Vaccination Sales by Application (2017-2022) & (Units)
Table 65. Global Human Rabies Vaccination Sales by Application (2023-2028) & (Units)
Table 66. Global Human Rabies Vaccination Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Human Rabies Vaccination Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Human Rabies Vaccination Price by Application (2017-2022) & (US$/Unit)
Table 69. Global Human Rabies Vaccination Price by Application (2023-2028) & (US$/Unit)
Table 70. North America Human Rabies Vaccination Sales by Country (2017-2022) & (Units)
Table 71. North America Human Rabies Vaccination Sales by Country (2023-2028) & (Units)
Table 72. North America Human Rabies Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Human Rabies Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Human Rabies Vaccination Sales by Type (2017-2022) & (Units)
Table 75. North America Human Rabies Vaccination Sales by Type (2023-2028) & (Units)
Table 76. North America Human Rabies Vaccination Sales by Application (2017-2022) & (Units)
Table 77. North America Human Rabies Vaccination Sales by Application (2023-2028) & (Units)
Table 78. Europe Human Rabies Vaccination Sales by Country (2017-2022) & (Units)
Table 79. Europe Human Rabies Vaccination Sales by Country (2023-2028) & (Units)
Table 80. Europe Human Rabies Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Human Rabies Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Human Rabies Vaccination Sales by Type (2017-2022) & (Units)
Table 83. Europe Human Rabies Vaccination Sales by Type (2023-2028) & (Units)
Table 84. Europe Human Rabies Vaccination Sales by Application (2017-2022) & (Units)
Table 85. Europe Human Rabies Vaccination Sales by Application (2023-2028) & (Units)
Table 86. Asia-Pacific Human Rabies Vaccination Sales by Region (2017-2022) & (Units)
Table 87. Asia-Pacific Human Rabies Vaccination Sales by Region (2023-2028) & (Units)
Table 88. Asia-Pacific Human Rabies Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Human Rabies Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Human Rabies Vaccination Sales by Type (2017-2022) & (Units)
Table 91. Asia-Pacific Human Rabies Vaccination Sales by Type (2023-2028) & (Units)
Table 92. Asia-Pacific Human Rabies Vaccination Sales by Application (2017-2022) & (Units)
Table 93. Asia-Pacific Human Rabies Vaccination Sales by Application (2023-2028) & (Units)
Table 94. South America Human Rabies Vaccination Sales by Country (2017-2022) & (Units)
Table 95. South America Human Rabies Vaccination Sales by Country (2023-2028) & (Units)
Table 96. South America Human Rabies Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Human Rabies Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Human Rabies Vaccination Sales by Type (2017-2022) & (Units)
Table 99. South America Human Rabies Vaccination Sales by Type (2023-2028) & (Units)
Table 100. South America Human Rabies Vaccination Sales by Application (2017-2022) & (Units)
Table 101. South America Human Rabies Vaccination Sales by Application (2023-2028) & (Units)
Table 102. Middle East & Africa Human Rabies Vaccination Sales by Region (2017-2022) & (Units)
Table 103. Middle East & Africa Human Rabies Vaccination Sales by Region (2023-2028) & (Units)
Table 104. Middle East & Africa Human Rabies Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Human Rabies Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Human Rabies Vaccination Sales by Type (2017-2022) & (Units)
Table 107. Middle East & Africa Human Rabies Vaccination Sales by Type (2023-2028) & (Units)
Table 108. Middle East & Africa Human Rabies Vaccination Sales by Application (2017-2022) & (Units)
Table 109. Middle East & Africa Human Rabies Vaccination Sales by Application (2023-2028) & (Units)
Table 110. Human Rabies Vaccination Raw Material
Table 111. Key Manufacturers of Human Rabies Vaccination Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Human Rabies Vaccination Typical Distributors
Table 115. Human Rabies Vaccination Typical Customers
List of Figures
Figure 1. Human Rabies Vaccination Picture
Figure 2. Global Human Rabies Vaccination Revenue Market Share by Type in 2021
Figure 3. Vero Cell
Figure 4. BHK
Figure 5. Chick Embryo Cell
Figure 6. Human Diploid Cells
Figure 7. Others
Figure 8. Global Human Rabies Vaccination Revenue Market Share by Application in 2021
Figure 9. Pre-exposure
Figure 10. Post-exposure
Figure 11. Global Human Rabies Vaccination Revenue, (USD Million) & (Units): 2017 & 2021 & 2028
Figure 12. Global Human Rabies Vaccination Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Human Rabies Vaccination Sales (2017-2028) & (Units)
Figure 14. Global Human Rabies Vaccination Price (2017-2028) & (US$/Unit)
Figure 15. Global Human Rabies Vaccination Production Capacity (2017-2028) & (Units)
Figure 16. Global Human Rabies Vaccination Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Human Rabies Vaccination Market Drivers
Figure 18. Human Rabies Vaccination Market Restraints
Figure 19. Human Rabies Vaccination Market Trends
Figure 20. Global Human Rabies Vaccination Sales Market Share by Manufacturer in 2021
Figure 21. Global Human Rabies Vaccination Revenue Market Share by Manufacturer in 2021
Figure 22. Human Rabies Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Human Rabies Vaccination Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Human Rabies Vaccination Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Human Rabies Vaccination Sales Market Share by Region (2017-2028)
Figure 26. Global Human Rabies Vaccination Revenue Market Share by Region (2017-2028)
Figure 27. North America Human Rabies Vaccination Revenue (2017-2028) & (USD Million)
Figure 28. Europe Human Rabies Vaccination Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Human Rabies Vaccination Revenue (2017-2028) & (USD Million)
Figure 30. South America Human Rabies Vaccination Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Human Rabies Vaccination Revenue (2017-2028) & (USD Million)
Figure 32. Global Human Rabies Vaccination Sales Market Share by Type (2017-2028)
Figure 33. Global Human Rabies Vaccination Revenue Market Share by Type (2017-2028)
Figure 34. Global Human Rabies Vaccination Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Human Rabies Vaccination Sales Market Share by Application (2017-2028)
Figure 36. Global Human Rabies Vaccination Revenue Market Share by Application (2017-2028)
Figure 37. Global Human Rabies Vaccination Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Human Rabies Vaccination Sales Market Share by Type (2017-2028)
Figure 39. North America Human Rabies Vaccination Sales Market Share by Application (2017-2028)
Figure 40. North America Human Rabies Vaccination Sales Market Share by Country (2017-2028)
Figure 41. North America Human Rabies Vaccination Revenue Market Share by Country (2017-2028)
Figure 42. United States Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Human Rabies Vaccination Sales Market Share by Type (2017-2028)
Figure 46. Europe Human Rabies Vaccination Sales Market Share by Application (2017-2028)
Figure 47. Europe Human Rabies Vaccination Sales Market Share by Country (2017-2028)
Figure 48. Europe Human Rabies Vaccination Revenue Market Share by Country (2017-2028)
Figure 49. Germany Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Human Rabies Vaccination Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Human Rabies Vaccination Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Human Rabies Vaccination Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Human Rabies Vaccination Revenue Market Share by Region (2017-2028)
Figure 58. China Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Human Rabies Vaccination Sales Market Share by Type (2017-2028)
Figure 65. South America Human Rabies Vaccination Sales Market Share by Application (2017-2028)
Figure 66. South America Human Rabies Vaccination Sales Market Share by Country (2017-2028)
Figure 67. South America Human Rabies Vaccination Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Human Rabies Vaccination Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Human Rabies Vaccination Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Human Rabies Vaccination Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Human Rabies Vaccination Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Human Rabies Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Human Rabies Vaccination in 2021
Figure 79. Manufacturing Process Analysis of Human Rabies Vaccination
Figure 80. Human Rabies Vaccination Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ヒト用狂犬病ワクチン接種のグローバル市場展望 2023年-2029年：ベロ細胞、BHK、ニワトリ胚細胞、ヒト二倍体細胞、その他
  • 世界の狂犬病予防接種市場2022年：市場規模予測（～2028年）
  • 人間用凍結乾燥狂犬病ワクチン（ヒト二倍体細胞）のグローバル市場展望 2023年-2029年：バイアル、充填済み
  • 世界のヒト狂犬病免疫グロブリン（HRIG）市場2022年：市場規模予測（～2028年）
  • 世界のヒト用ワクチン接種市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19398 )"世界の人間用狂犬病予防接種市場2022年：市場規模予測（～2028年）" (英文：Global Human Rabies Vaccination Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。